💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Incyte Corporation (INCY)
« Back to company indexINCY Chatter Timeline
Stock Ticker for INCY
Most Active Tweeters for INCY
| User | Tweets |
|---|---|
| @mediasentiment | 14 |
| @InsiderAlerts4U | 11 |
| @FlashAlert_me | 10 |
| @Tickeron | 8 |
| @newsfilterio | 7 |
Recent Tweets for INCY
 |
@dhovekamp42 RT @bradloncar: $INCY is withdrawing the New Drug Application (NDA) for parsaclisib for the treatment of patients with relapsed or refracto… 12:01am |
 |
@StckPro $INCY NEW ARTICLE : Mizuho Securities Sticks to Its Hold Rating for Incyte (INCY) https://t.co/N9O2Ke7doR Get all t… https://t.co/U3HKcyuWLl 12:01am |
 |
@SVENNIECO Incyte drops US filing for parsaclisib in non-Hodgkin lymphomas $INCY $MRUS https://t.co/hPYygpmtTK January 25th 2022, 11:01pm |
|
@SVENNIECO Incyte drops US filing for parsaclisib in non-Hodgkin lymphomas $INCY $MRUS https://t.co/o2FiLc1cNY January 25th 2022, 11:01pm |
 |
@Briefingcom $INCY: Incyte withdraws NDA for parsaclisib; confirms opt-out of development of MCLA-145 https://t.co/yCWwk0Q0pr January 25th 2022, 11:01pm |
 |
@fwpharma Incyte drops US filing for parsaclisib in non-Hodgkin lymphomas $INCY $MRUS https://t.co/xdgK8DrX1q January 25th 2022, 11:01pm |
 |
@newsfilterio Incyte Provides Update on Parsaclisib and MCLA-145 $INCY https://t.co/fM6LNxIbDo January 25th 2022, 11:01pm |
 |
@MarcJacksonLA $INCY $MRUS Incyte Provides Update on Parsaclisib and MCLA-145 https://t.co/BIozmsZA5s January 25th 2022, 11:01pm |
|
@newsfilterio Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145 $INCY $MRUS https://t.co/R3BCO4qqzi January 25th 2022, 10:01pm |
|
@StckPro $INCY NEW ARTICLE : Incyte Provides Update on Parsaclisib and MCLA-145 https://t.co/XfM0TBijCO Get all the latest… https://t.co/VZ4Cm6fsiF January 25th 2022, 9:01pm |
 |
@Sanctuary_Bio not gonna lie, I was surprised when $INCY was an ASH winner, I didn't think the data was that competitive oh well,… https://t.co/MK46izoFpj January 25th 2022, 9:01pm |
 |
@newsinthemarket Incyte withdraws NDA for parsaclisib, opts out from further MCLA-145 development $INCY January 25th 2022, 9:01pm |
 |
@phasefivebot $INCY Incyte Provides Update on Parsaclisib and MCLA-145 https://t.co/WFC101f16F January 25th 2022, 9:01pm |
 |
@MarketNFlash Merus Appoints Shannon Campbell As Chief Commercial Officer And Regains Worldwide Rights To MCLA-145 | $INCY $MRUS January 25th 2022, 9:01pm |
 |
@bradloncar $INCY is withdrawing the New Drug Application (NDA) for parsaclisib for the treatment of patients with relapsed or… https://t.co/yuRyAAvoFX January 25th 2022, 9:01pm |
 |
@FlashAlert_me $INCY [15s. delayed]: Issued Press Release on January 25, 16:30:00: Incyte Provides Update on Parsaclisib and MCLA-… https://t.co/QUkU0G7yJV January 25th 2022, 9:01pm |
 |
@ZoZoStockwatch RT @TheTradeXchange: $INCY: Incyte Provides Update on Parsaclisib and MCLA-145 January 25th 2022, 9:01pm |
 |
@StockNewsBot2 $INCY Incyte Provides Update on Parsaclisib and MCLA-145 https://t.co/Rn30Qw9pYI January 25th 2022, 9:01pm |
 |
@TheTradeXchange $INCY: Incyte Provides Update on Parsaclisib and MCLA-145 January 25th 2022, 9:01pm |
 |
@stock_titan $INCY Incyte Provides Update on Parsaclisib and MCLA-145 https://t.co/F9mtMMtKV8 January 25th 2022, 9:01pm |
 |
@perrone_ken RT @bio_clouseau: Regarding $SRRA Momelotinib vs $INCY Rux, simplify-1 gives an answer albeit in jak naive MF patients https://t.co/mKF6asX… January 25th 2022, 2:01pm |
 |
@BayAreaBiotechI $SRRA back to Dec. 2021 highs on positive ph3 #MF data today. I guess in this market that is a win? $INCY #ruxwatchout January 25th 2022, 2:01pm |
 |
@bio_clouseau Regarding $SRRA Momelotinib vs $INCY Rux, simplify-1 gives an answer albeit in jak naive MF patients https://t.co/mKF6asXzDl January 25th 2022, 12:01pm |
 |
@DoraWri58503474 $INCY *Hey guys, I've made $55K with them in a week, by their alerts ,._, https://t.co/2VrS0WNsPk January 25th 2022, 3:01am |
 |
@Thestory0fmoney $INCY https://t.co/aRINTKCFXU January 25th 2022, 1:01am |
 |
@mediasentiment $INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 843 January 24th 2022, 9:01pm |
 |
@ChartMill Our 'Technical Setups in Strongly Growing Stocks' lists $INCY today! https://t.co/vmjZdBXHkD January 24th 2022, 9:01pm |
|
@ChartMill Our 'Technical Setups in Strongly Growing Stocks' lists $INCY today! https://t.co/BHiDVVTVaM January 24th 2022, 5:01pm |
 |
@Ba4Saso $INCY Waiting for Short signal. Chart by https://t.co/z6vAd7dl0q https://t.co/GrLRFMZXbG January 24th 2022, 5:01pm |
 |
@LancerLancer_ @TaPlot @11dbrowns $INCY January 24th 2022, 3:01pm |
 |
@ShortAlgoKing $INCY Awaiting Short Signal. Chart by https://t.co/qchl9O5K2n https://t.co/YPzT6wgmQw January 24th 2022, 11:01am |
|
@mediasentiment $INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 369 January 24th 2022, 11:01am |
 |
@InvestorSimply $INCY - Incyte: Still Has Room To Grow. https://t.co/KKmBKPgDSV #investing #finance #stockmarket January 24th 2022, 8:01am |
|
@newsfilterio Incyte: Still Has Room To Grow $INCY https://t.co/d1AycCjNYZ January 24th 2022, 5:01am |
|
@StckPro $INCY NEW ARTICLE : Incyte: Still Has Room To Grow https://t.co/iC83vwBbhR Get all the latest $INCY related news he… https://t.co/mkVs2Vqpra January 24th 2022, 5:01am |
 |
@SeekingAlpha $INCY - Incyte: Still Has Room To Grow. https://t.co/ULsAJ34NiA #investing #finance #stockmarket January 24th 2022, 5:01am |
 |
@dafster17 $INCY https://t.co/fMVadu0W0d January 24th 2022, 4:01am |
 |
@optioncharts $INCY Implied Volatility expiration 02/18/2022 #maxpain #options https://t.co/Smo479v48n https://t.co/OgqCsBfSVf January 24th 2022, 2:01am |
|
@mediasentiment $INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 13 January 24th 2022, 1:01am |
|
@MarcJacksonLA $INCY Incyte Expected to Post Quarterly Sales of $826.27 Million | https://t.co/NKb5pRLCDo https://t.co/HUND12UmND January 23rd 2022, 3:01pm |
 |
@Tickeron $INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on January 14, 2022. View odds for this and… https://t.co/fLqATW42DY January 23rd 2022, 11:01am |
|
@mediasentiment $INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 306 January 23rd 2022, 11:01am |
|
@mediasentiment $INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 305 January 23rd 2022, 11:01am |
 |
@SamuelK32972932 $INCY ~Find active market alerts here in this best trading community.https://t.co/kmu9qtltyP January 23rd 2022, 2:01am |
 |
@FinancialAdvBot Buy the dip $INCY! https://t.co/7VLTGRYRlV January 23rd 2022, 2:01am |
|
@Tickeron $INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on January 14, 2022. View odds for this and othe… https://t.co/olUPtoUZ5P January 22nd 2022, 11:01pm |
|
@optioncharts $INCY Implied Volatility expiration 02/18/2022 #maxpain #options https://t.co/Smo479v48n https://t.co/dwpCee8QAM January 22nd 2022, 7:01pm |
|
@mediasentiment $INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 205 January 22nd 2022, 10:01am |
 |
@InsiderAlerts4U $INCY: New Insider Filing on INCYTE CORP's EVP & General Counsel MARIA E PASQUALE: https://t.co/rkCyAiVS2l January 22nd 2022, 8:01am |
 |
@Jhswings27 $INCY volume breaking out the further this goes down the channel. Move to $82 volume shelf coming. https://t.co/IE6ROm5xTy January 22nd 2022, 7:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?